Business
MYND Life Sciences Inc. Announces the Appointment of Mr. John Campbell as President and Chief Executive Officer
Vancouver, British Columbia--(Newsfile Corp. - December 5, 2023) - MYND Life Sciences  (CSE...
About this update from Mynd Life Sciences Inc
[{"type":"text","content":"MYND Life Sciences Inc. Announces the Appointment of Mr. John Campbell as President and Chief Executive OfficerVancouver, British Columbia--(Newsfile Corp. - December 5, 2023) - MYND Life Sciences (CSE: MYND) (OTCQB: MYNDF) (\"MYND\" or the \"Company\"), a pioneering biopharmaceutical research and development company committed to advancing treatments for patients coping with chronic and acute neurological and inflammatory diseases, is delighted to announce the immediate appointment of Mr. John (Jay) Campbell as President and Chief Executive Officer.Mr. Campbell is distinguished for his expertise in financial services and brings a vast repertoire of experience in new business development, mergers, acquisitions, and corporate turnarounds. His pragmatic approach and strategic proficiency are evident in his guidance of professionals within competitive industries. Moreover, he was the President and Co-Founder of Odyssey Trust Company, a North American transfer agent that has effectively reshaped the industry's benchmarks for transfer agent and trust services. Mr. Campbell holds a Bachelor's Degree in Commerce, which he earned with distinction from the University of Alberta, and an ICD.D designation from the Institute of Corporate Directors.In outlining MYND's strategy, Mr. Campbell states, \"The opportunities for MYND to commercialize its tremendous portfolio of intellectual property are enormous and I am committed to translating MYND's industry-leading research into practical advancements, particularly in neuro pharmaceutical treatments and diagnostic tools for diseases that can positively impact society.\"Dr. Lyle Oberg, MYND's Executive Chairman, states, \"With a focus on biopharmaceutical research and development, MYND aims to redefine treatments for inflammatory and neurological diseases and Mr. Campbell has a proven track record in leading public and private companies, and his appointment now positions MYND for success in the near term.\"ABOUT MYND LIFE SCIENCES INC.MYND Life Sciences Inc. is a medical biotech drug research and development company focused on neuro-pharmaceutical and novel drug development, diagnostics, and vaccines. MYND is developing new biological entities (NBEs) and new chemical entities (NCEs) and differentiates itself from other (bio)pharmaceutical companies by unique molecular concepts for ...